Stay updated on ONC-392 & Pembrolizumab in Platinum Resistant Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the ONC-392 & Pembrolizumab in Platinum Resistant Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ONC-392 & Pembrolizumab in Platinum Resistant Ovarian Cancer Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The history now adds a new Revision: v3.6.2 entry and removes the previous Revision: v3.6.0 entry, indicating an update to the page's underlying revision in the record history.
    Difference
    0.1%
    Check dated 2026-06-29T17:50:58.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    Added 'No longer looking for participants' to the study history, indicating recruitment is paused. The history also shows a new 'Revision: v3.6.0' entry and the removal of the previous 'Revision: v3.5.5' entry.
    Difference
    0.4%
    Check dated 2026-06-15T08:47:21.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    A newer revision entry (v3.5.5) was added to the study's version history, replacing the previous revision (v3.5.4) and signaling an update to the record metadata.
    Difference
    0.1%
    Check dated 2026-06-08T05:32:14.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    Footer now shows Revision: v3.5.4, replacing the previous v3.5.3, indicating a minor site release update. The update does not alter study content or how users interact with the page.
    Difference
    0.1%
    Check dated 2026-05-18T03:45:09.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    The page’s revision/version indicator was updated from v3.5.2 to v3.5.3. This represents a site release/version change rather than a modification to the clinical trial record content.
    Difference
    0.1%
    Check dated 2026-04-26T13:45:13.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    Added a 2026-04-13 entry for Study Status and updated to Revision: v3.5.2, with an accompanying 2026-04-08 entry; removed Revision: v3.5.0.
    Difference
    0.5%
    Check dated 2026-04-19T04:58:16.000Z thumbnail image

Stay in the know with updates to ONC-392 & Pembrolizumab in Platinum Resistant Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ONC-392 & Pembrolizumab in Platinum Resistant Ovarian Cancer Clinical Trial page.